Discovery and X-ray Crystallographic Analysis of a Iminohydantoin Inhibitor of beta-Secretase
Barrow, J.C., Stauffer, S.R., Rittle, K.E., Ngo, P.L., Yang, M.S., Graham, S., McGaughey, G., Holloway, K., Tugusheva, S.K., Lai, M., Espeseth, A.S., Xu, M., Huang, Q., Zuck, P., Levorse, D.A., Hazuda, D., Vacca, J.P.(2008) J Med Chem 51: 6259-6262
- PubMed: 18811140 
- DOI: https://doi.org/10.1021/jm800914n
- Primary Citation of Related Structures:  
3FKT - PubMed Abstract: 
A high-throughput screen at 100 microM inhibitor concentration for the BACE-1 enzyme revealed a novel spiropiperidine iminohydantoin aspartyl protease inhibitor template. An X-ray cocrystal structure with BACE-1 revealed a novel mode of binding whereby the inhibitor interacts with the catalytic aspartates via bridging water molecules. Using the crystal structure as a guide, potent compounds with good brain penetration were designed.
Organizational Affiliation: 
Department of Medicinal Chemistry, Merck Research Laboratories, West Point, Pennsylvania 19486, USA. james_barrow@merck.com